logo
episode-header-image
Aug 19
11m 48s

CT Colonography vs Multitarget Stool DNA

THE RADIOLOGICAL SOCIETY OF NORTH AMERICA
About this episode

Dr. Refky Nicola speaks with Dr. Perry Pickhardt about his study comparing CT colonography and multi-targeted stool DNA testing for colorectal cancer screening. They explore differences in sensitivity, specificity, cost-effectiveness, and strategies to optimize detection while minimizing invasiveness.

CT Colonography versus Multitarget Stool DNA Test forColorectal Cancer Screening: A Cost-Effectiveness Analysis. Pickhardt et al. Radiology 2025; 315(3):e243775.

Up next
Oct 7
From Notes to Data: NLP and Transformers in Radiology
Dr. Linda Chiu unpacks how natural language processing and large language models are transforming radiology, with insights from a review by Dr. Felipe Kitamura and colleagues. From tokenization to transformers, she explores both the promise and challenges of applying these powerf ... Show More
21m 17s
Sep 23
Crohn’s Strictures: New Guidelines and Future Directions
Dr. Refky Nicola speaks with Dr. Bari Dane, Associate Professor of Radiology at NYU, about the new SAR consensus recommendations for defining small bowel Crohn’s disease strictures on CT and MR enterography. They explore updated imaging criteria, the challenges of distinguishing ... Show More
11m 44s
Sep 16
Imaging Consensus for Post-COVID Lungs
Dr. Lauren Kim speaks with Dr. Anna Rita Larici about the international consensus guidelines for imaging and managing post-COVID-19 residual lung abnormalities. They discuss the importance of standardized definitions, CT imaging protocols, and unified terminology to guide diagnos ... Show More
21m 40s
Recommended Episodes
Sep 24
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Aug 22
How MRD Testing is Reshaping Breast Cancer Recurrence Monitoring
In this episode of OncoTalks, Dr. Paul Conkling and Dr. Kashif Ali explore how minimal residual disease (MRD) testing using circulating tumor DNA (ctDNA) is reshaping breast cancer management. They discuss how this innovative approach enables the detection of molecular disease th ... Show More
9m 2s
Sep 4
Colorectal Cancer
Ninja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob discuss Colorectal Cancer. This comprehensive discussion focuses on the clinical presentation, pathogenesis, and management of one of the most common malignancies encountered in clinical practice.We start by brea ... Show More
37m 25s
Feb 2022
Episode 005: Heme Path Series Pt. 4 - Molecular Testing
Molecular Testing PearlsIn Part 4 of our Heme Path series, we thoroughly examine the details of molecular testing and how it relates to hematologic and oncologic malignancies I. Molecular Testing BasicsA. Provides a means of assessing patient’s genotypes, specifically at smaller ... Show More
30m 36s
Aug 20
Episode 64. Lymphoma Updates from EHA and ICML 2025 with Dr. Adrian Minson
In this episode of Blood Cancer Talks, we have Dr. Adrian Minson from the Peter MacCallum Cancer Centre to discuss the latest developments in lymphoma presented at the recent EHA and ICML meetings in June 2025. The episode focuses primarily on the emerging role of bispecific anti ... Show More
43m 3s
Jul 2024
S2 Episode 4: The Evolution of Nonoperative Rectal Cancer Management
Join Drs Benjamin Schlechter and Joshua Smith as they discuss the evolution of nonoperative rectal cancer management and organ preservation, highlighting groundbreaking trials like OPRA and JANUS. Relevant disclosures can be found with the episode show notes on Medscape https://w ... Show More
26m 27s
Feb 2024
EKU Podcast: Faecal immunochemical testing
Colorectal cancer is the fourth most common type of cancer in the UK, with over 40,000 new cases each year. The positive predictive value of Faecal immunochemical testing (FIT) far exceeds that of symptoms and makes FIT an important tool for triaging patients with symptoms sugges ... Show More
21m 21s
Nov 2024
Surgical Oncology, Part 1
In this first episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is joined by Drs. John Stewart and Prakash Pendalai to discuss the genetic and molecular features of cancer. They also discuss screening methods and other preventive interventions, with a ... Show More
28m 14s
Aug 2024
S2 Episode 5: Adjuvant Chemo in Colorectal Cancer: What's Working Now?
Join Drs Benjamin Schlechter and Jeff Meyerhardt as they discuss the latest breakthroughs in adjuvant chemo for CRC and share their decision-making in real-world scenarios. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarti ... Show More
24m 52s
Mar 2025
Demystifying Genetics with Erica Spaeth
Send us a text This episode dives into polygenic risk testing, exploring how genetic data can inform healthcare strategies. We discuss the complexities of communicating risk, the role of polygenic scores in identifying disease susceptibility, and the evolving landscape of persona ... Show More
49m 41s